Louis Létinier

486 total citations
22 papers, 285 citations indexed

About

Louis Létinier is a scholar working on Toxicology, Geriatrics and Gerontology and Oncology. According to data from OpenAlex, Louis Létinier has authored 22 papers receiving a total of 285 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Toxicology, 4 papers in Geriatrics and Gerontology and 4 papers in Oncology. Recurrent topics in Louis Létinier's work include Pharmacovigilance and Adverse Drug Reactions (7 papers), Pharmaceutical Practices and Patient Outcomes (4 papers) and Biosimilars and Bioanalytical Methods (3 papers). Louis Létinier is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (7 papers), Pharmaceutical Practices and Patient Outcomes (4 papers) and Biosimilars and Bioanalytical Methods (3 papers). Louis Létinier collaborates with scholars based in France, Italy and United States. Louis Létinier's co-authors include Francesco Salvo, Alexandre Pariente, Santa Cirmi, Michele Navarra, Joëlle Micallef, Julien Bezin, Yohann Mansiaux, Annie Fourrier‐Réglat, Sébastien Cossin and Frantz Thiessard and has published in prestigious journals such as Journal of Clinical Epidemiology, Clinical Pharmacology & Therapeutics and Frontiers in Pharmacology.

In The Last Decade

Louis Létinier

20 papers receiving 282 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Louis Létinier France 9 83 48 43 36 34 22 285
Mo Dimbil United States 6 144 1.7× 31 0.6× 36 0.8× 14 0.4× 37 1.1× 7 455
Valérie Gras France 11 35 0.4× 35 0.7× 36 0.8× 56 1.6× 57 1.7× 29 371
Eileen Wu United States 11 95 1.1× 73 1.5× 30 0.7× 15 0.4× 20 0.6× 23 378
Natsumi Ueda Japan 13 150 1.8× 59 1.2× 22 0.5× 24 0.7× 37 1.1× 24 468
Yamato Kato Japan 13 136 1.6× 48 1.0× 21 0.5× 28 0.8× 33 1.0× 25 423
Ryogo Umetsu Japan 13 168 2.0× 49 1.0× 27 0.6× 27 0.8× 42 1.2× 21 467
Pauline Bosco‐Lévy France 13 30 0.4× 64 1.3× 23 0.5× 23 0.6× 56 1.6× 31 399
Kenji Momo Japan 10 16 0.2× 26 0.5× 29 0.7× 28 0.8× 57 1.7× 76 314
Long Meng China 13 36 0.4× 47 1.0× 11 0.3× 78 2.2× 33 1.0× 31 379
Daniele Ugo Tari Italy 15 33 0.4× 37 0.8× 30 0.7× 72 2.0× 12 0.4× 30 499

Countries citing papers authored by Louis Létinier

Since Specialization
Citations

This map shows the geographic impact of Louis Létinier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louis Létinier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louis Létinier more than expected).

Fields of papers citing papers by Louis Létinier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Louis Létinier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louis Létinier. The network helps show where Louis Létinier may publish in the future.

Co-authorship network of co-authors of Louis Létinier

This figure shows the co-authorship network connecting the top 25 collaborators of Louis Létinier. A scholar is included among the top collaborators of Louis Létinier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louis Létinier. Louis Létinier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Rozenberg, Julian M., Noémie Simon‐Tillaux, David Hajage, et al.. (2024). A methodological review of the high-dimensional propensity score in comparative-effectiveness and safety-of-interventions research finds incomplete reporting relative to algorithm development and robustness. Journal of Clinical Epidemiology. 169. 111305–111305. 1 indexed citations
3.
Létinier, Louis, et al.. (2023). Drug–Drug Interactions and the Risk of Emergency Hospitalizations: A Nationwide Population-Based Study. Drug Safety. 46(5). 449–456. 3 indexed citations
4.
Daoud, F., Louis Létinier, Nicholas Moore, Pierre Coste, & Pasi P. Karjalainen. (2022). Efficacy and Safety of TiNO-Coated Stents versus Drug-Eluting Stents in Acute Coronary Syndrome: Systematic Literature Review and Meta-Analysis. Biomedicines. 10(12). 3159–3159. 3 indexed citations
5.
Bennetau‐Pelissero, Catherine, et al.. (2022). Herb-drug interaction resources: The PHYDGI database. Phytomedicine Plus. 2(3). 100324–100324. 3 indexed citations
6.
Mathieu, Clément, Louis Létinier, Annie Fourrier‐Réglat, et al.. (2022). Psychoactive substance use among students: A cross‐sectional analysis. Fundamental and Clinical Pharmacology. 36(5). 908–914. 20 indexed citations
7.
Pariente, Alexandre, Joëlle Micallef, Mathiéu Molimard, et al.. (2022). What place for intelligent automation and artificial intelligence to preserve and strengthen vigilance expertise in the face of increasing declarations?. Therapies. 78(1). 131–143. 4 indexed citations
8.
9.
Létinier, Louis, M. Benkebil, Franck Rouby, et al.. (2021). Artificial Intelligence for Unstructured Healthcare Data: Application to Coding of Patient Reporting of Adverse Drug Reactions. Clinical Pharmacology & Therapeutics. 110(2). 392–400. 22 indexed citations
10.
Létinier, Louis, et al.. (2021). Spontaneous Reports of Serious Adverse Drug Reactions Resulting From Drug–Drug Interactions: An Analysis From the French Pharmacovigilance Database. Frontiers in Pharmacology. 11. 624562–624562. 17 indexed citations
11.
Noïze, Pernelle, et al.. (2020). Safety profile of drugs for advanced melanoma: A report based on 2008–2018 US Food and Drug Administration Data. British Journal of Clinical Pharmacology. 87(7). 2988–2995. 1 indexed citations
12.
13.
14.
Létinier, Louis, Sébastien Cossin, Yohann Mansiaux, et al.. (2019). Risk of Drug-Drug Interactions in Out-Hospital Drug Dispensings in France: Results From the DRUG-Drug Interaction Prevalence Study. Frontiers in Pharmacology. 10. 265–265. 29 indexed citations
15.
Létinier, Louis, Yohann Mansiaux, Alexandre Pariente, & Annie Fourrier‐Réglat. (2018). Impact of cancer diagnosis on persistence of oral antidiabetic drugs. Diabetes Research and Clinical Practice. 139. 323–330. 5 indexed citations
16.
Létinier, Louis, et al.. (2018). Consommation de substances psychoactives : un état des lieux au sein des étudiants de la cohorte i-Share. Therapies. 73(6). 575–575. 5 indexed citations
17.
Létinier, Louis, Sébastien Cossin, Yohann Mansiaux, et al.. (2018). Prévalence et description des situations à risque d’interactions médicamenteuses en France à partir des données de l’Assurance maladie. Revue d Épidémiologie et de Santé Publique. 66. S22–S22.
18.
Daveluy, Amélie, et al.. (2017). Parachuting psychoactive substances: Pharmacokinetic clues for harm reduction. Addictive Behaviors. 78. 173–177. 2 indexed citations
19.
Salvo, Francesco, Julien Bezin, Pauline Bosco‐Lévy, et al.. (2016). Pharmacological treatments of cardiovascular diseases: Evidence from real-life studies. Pharmacological Research. 118. 43–52. 18 indexed citations
20.
Grellety, Thomas, Sophie Cousin, Louis Létinier, et al.. (2016). PRognostic factor of Early Death In phase II Trials or the end of ‘sufficient life expectancy’ as an inclusion criterion? (PREDIT model). BMC Cancer. 16(1). 768–768. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mo Dimbil Breakdown of academic impact, for papers by Valérie Gras Breakdown of academic impact, for papers by Eileen Wu Breakdown of academic impact, for papers by Natsumi Ueda Breakdown of academic impact, for papers by Yamato Kato Breakdown of academic impact, for papers by Ryogo Umetsu Breakdown of academic impact, for papers by Pauline Bosco‐Lévy Breakdown of academic impact, for papers by Kenji Momo Breakdown of academic impact, for papers by Long Meng Breakdown of academic impact, for papers by Daniele Ugo Tari
Rankless by CCL
2026